Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.59

-0.9%

Oct 30 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (1429)	6/4/2003 11:48:40 PM
From: scaram(o)uche	Read Replies (1) of 1475

Some SI biofreaks did what they could to talk management out of buying Eligix. A group of us visited the company in Spring 2001 for an update, and to argue against the purchase before it closed. I found this comment from about that time. I remember others, but I can't find them...... Message 15147235 This was my comment a year after the deal, when Eligix wasn't selling..... Message 16777038 Message 16777118 When XenoMune was spun out, it left BioTransplant without a project that had commercial viability. Eligix was brought in to support, in essence, an experimental protocol, AlloMune. Square peg, round hole. Ugly, ugly, ugly. One good thing..... guess Eligix is now in the realm of SI's own Richard Reeves and coworkers??

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next